Moser, Tobias
Zimmermann, Georg
Baumgartner, Anna
Berger, Thomas
Bsteh, Gabriel
Di Pauli, Franziska
Enzinger, Christian
Fertl, Elisabeth
Heller, Thomas
Koppi, Stefan
Rommer, Paulus S.
Safoschnik, Georg
Seifert-Held, Thomas
Stepansky, Robert
Sellner, Johann http://orcid.org/0000-0001-8749-5533
Article History
Received: 26 May 2023
Revised: 28 July 2023
Accepted: 6 August 2023
First Online: 20 September 2023
Declarations
:
: T.M. has received travel support, honoraria for presentations or participation on advisory boards from Biogen Idec, Celgene, Novartis, Roche, Sanofi, Merck and Teva. A.B. received travel support from Biogen, Novartis and Sanofi/Genzyme. T.B. has participated in meetings sponsored by and received honoraria (lectures, advisory boards, and consultations) from pharmaceutical companies marketing treatments for MS: Allergan, Almirall, Bayer, Biogen, Biologix, Bionorica, Celgene/Bristol Myers Squibb (BMS), GlaxoSmithKline (GSK), Janssen-Cilag, Medday, Merck, Novartis, Octapharma, Roche, Sanofi Genzyme, Teva, and TG Pharmaceuticals. G.B. has participated in meetings sponsored by, received speaker honoraria or travel funding from Biogen, Celgene/BMS, Lilly, Merck, Novartis, Roche, Sanofi-Genzyme and Teva, and received honoraria for consulting Biogen, Celgene/BMS, Merck, Novartis, Roche, Sanofi-Genzyme and Teva. He has received financial support in the past 12 months by unrestricted research grants (Celgene/BMS, Novartis). F.DP. has participated in meetings sponsored by, received honoraria (lectures, advisory boards, consultations) or travel funding from Bayer, Biogen, Horizon, Janssen-Cilag, Merck, Novartis, Sanofi-Genzyme, Teva, Celgene and Roche. Her institution has received research grants from Roche. C.E. has received funding for travel and speaker honoraria from Biogen, Bayer, Merck, Novartis, Roche, Shire, Genzyme, and Teva; has received research support from Biogen, Merck, and Teva; and is serving on scientific advisory boards for Bayer, Biogen, Celgene/BMS, Merck, Novartis, Roche, and Teva. E.F. has participated in advisory boards and scientific meetings, she also received honoraria for lectures and travel funding on behalf of Biogen, Celgene/BMS, Novartis, Janssen, Sanofi-Genzyme and Teva. P.SR. received honorary for lectures or consultancy from Alexion, Allmiral, Amicus, Biogen, Genzyme, Horizon, Merck, Novartis, Roche, Sandoz, Teva; and received research grants from Amicus, Merck and Roche. G.S. received honoraria for participation in advisory boards and travel support from Schering, Biogen Idec, Sanofi, Teva, Genzyme, Roche, Merck, Novartis, Pfizer. J.S. received honoraria for lectures, preparation of teaching material, and participation in scientific advisory boards from Astra Zeneca, Biogen, BMS/Celgene, Horizon, Immunic, Janssen, Lundbeck, Merck, Novartis, Pfizer, Roche, Sandoz and Sanofi. The remaining authors report no competing interests.